Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 3/20 | 0.43 |
| ▸ | CTSS | P25774 | 3/20 | 0.43 |
| ▸ | TGM2 | P21980 | 2/20 | 0.43 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.43 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 6/20 | 0.41 |
| ▸ | MME | P08473 | 2/20 | 0.40 |
| ▸ | ECE1 | P42892 | 1/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | CTSH | P09668 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19689233 | 0.87 | FOLH1 (0.45) | TGM2CA2ECE1FOLH1 | |
| SCHEMBL9832048 | 0.81 | NOD1 (0.49) | CTSLCTSSTGM2SIRT2SIRT1 | |
| SCHEMBL9832042 | 0.81 | NOD1 (0.49) | CTSLCTSSTGM2SIRT2SIRT1 | |
| SCHEMBL9830451 | 0.76 | NOD1 (0.47) | CTSLCTSSTGM2SIRT2SIRT1 | |
| SCHEMBL9830456 | 0.76 | NOD1 (0.47) | CTSLCTSSTGM2SIRT2SIRT1 | |
| SCHEMBL1077922 | 0.76 | NOD1 (0.48) | CTSLCTSSTGM2SIRT2SIRT1 | |
| SCHEMBL6269749 | 0.76 | NOD1 (0.51) | TGM2SIRT2SIRT1NOD1FOLH1 | |
| SCHEMBL7382637 | 0.76 | NOD1 (0.48) | CTSLCTSSTGM2SIRT2SIRT1 | |
| SCHEMBL1000115 | 0.76 | TLR2 (0.62) | TLR2MDM2 | |
| SCHEMBL1044856 | 0.76 | TLR2 (0.62) | TLR2MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250115626-A1 | BIFUNCTIONAL LINKER COMPRISING METAALLYLSILANE AND METHOD FOR PREPARING SAME | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2025-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250115626-A1 | BIFUNCTIONAL LINKER COMPRISING METAALLYLSILANE AND METHOD FOR PREPARING SAME | MSN, MTCL3, TLN1 | CTSL 478/4885CTSS 1426/4885TGM2 3790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.